Gemstone Biotherapeutics Private
Gemstone Biotherapeutics is a pre-clinical research and development initiative based in Baltimore, Maryland. The organization is dedicated to the field of regenerative medicine and focuses on developing improved methods for advanced wound healing and tissue vascularization. They specialize in using licensed technology from Johns Hopkins University, including innovative polymeric hydrogels and stem cell engineering methodologies. Gemstone Biotherapeutics aims to revolutionize the field of regenerative medicine and make significant advancements in the treatment of wounds and tissue repair.
%20University%20System%20of%20Maryland.png)
Industry:
Stem Cells (Regenerative Medicine)
Technology:
Other
Estimated Revenue:
$10M to $50M
Investors Number:
5
Headquarters:
United States
Employee Number:
2
Total Funding:
$69.9M
Last Funding Type:
Post-IPO Equity